
Banks, Jack Dorsey, India, and Gene Editing (Podcast)
About this episode
Bloomberg News Macro Strategist Cam Crise joins the program to break down how traders are pricing in the Fed’s rate moves this week and outlook for markets amid bank uncertainty. Jenny Surane, finance reporter with Bloomberg News, joins the program to discuss Hindenburg short selling Block and crushing a portion of Jack Dorsey’s wealth, as well as Hindenburg’s recent involvement with Adani Group. Scott Harrison, Portfolio Manager at Argent Capital Management, joins the program to talk about sectors he likes and outlook for equities. Rania Sedhom, Managing Partner of the Sedhom Group, joins the program to discuss her recent commentary on how the SVB breakdown affects the legal hurdles of acquiring funding. Sanjiv Sanyal, economist, author, and principal economic advisor to the Indian government and prime minister Narendra Modi, joins the discuss India’s growth potential, geopolitical balancing between China, Russia, and the US, and global economic and political uncertainty. Ali Urman, Genomics Analyst at ARK Invest (Fund: ARK Genomic Revolution ETF – ARKG), joins the program to talk about ETF investing in immunotherapy, gene editing, and the convergence of AI and tech in the health space. Hosted by Paul Sweeney and Jennifer Ryan.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Bloomberg Intelligence publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Bloomberg Intelligence

GE to Buy Consolidated Precision Products for $11.75 Billion
Bloomberg Intelligence

Introducing: Bloomberg Money
Bloomberg Intelligence

Bloomberg Money: Premium Travel, Fast Fashion, Luxury at the US Open & The Cost...
Bloomberg Intelligence

Anthropic Finalizing $15 Billion Pre-IPO Credit Facility
Bloomberg Intelligence